SERM Scientific Director
Leads safety evaluation and risk management for GSK's oncology assets in clinical development, providing scientific expertise to assess and communicate safety risks globally. Works cross-functionally to shape safety strategy, support regulatory submissions, and ensure patient protection. Focuses on signal detection, risk assessment, and strategic decision-making in a matrix environment.